Bluezone to enter life insurance industry amid £1.5m funding

Aims to "reinvent" traditional underwriting processes

Hemma Visavadia
clock • 1 min read

Insurtech Bluezone has received £1.5m in funding to help grow its life insurance business and launch its first life insurance product.

The funding round was led by Insurtech Gateway and AV8 Ventures, and included investors Oxford Capital, Portfolio Ventures and the chief executive of AXA, chief transformation officer at Aegon Group and the former chairman of NHS England. The start-up insurtech plans to use the investment to expand its team and launch its first product, a Type 2 Diabetes life insurance product. Bluezone aims to "reinvent" traditional underwriting processes which are often "outdated, manual and cumbersome" and ultimately makes it difficult for individuals with chronic conditions to access insurance. ...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Technology

Positive Q1 for protection: iPipeline

Positive Q1 for protection: iPipeline

APE up 17%

Cameron Roberts
clock 05 June 2025 • 1 min read
New Insight Zone dashboard launched by CIExpert

New Insight Zone dashboard launched by CIExpert

Acts as an overview for the existing Insight Zones

Jaskeet Briah
clock 02 June 2025 • 2 min read
Partner Insight: Making It Personal - Why we must treat customers like VIPs

Partner Insight: Making It Personal - Why we must treat customers like VIPs

Stuart Hayman, Senior Business Consultant - Life & Pensions Insurance Practice (EMEA & APAC), Sapiens
clock 30 April 2025 • 5 min read